Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | IL-9 | 68.0 | 81 | |
N2586 | Adiponectin | 5 | ng/mL | 3 | IL-9 | 82.0 | 71 | ||||
N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | IL-9 | 80.5 | 72 | |
N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | IL-9 | 74.5 | 78 | |
N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | IL-9 | 75.0 | 77 | |
N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | IL-9 | 81.0 | 81 | |
N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | IL-9 | 82.0 | 79 | |
RA2159 | IGF-I | 100 | ug/mL | 3 | IL-9 | 62.0 | 59 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | IL-9 | 68.0 | 82 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL-9 | 68.0 | 81 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL-9 | 73.0 | 74 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL-9 | 77.0 | 90 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | IL-9 | 62.0 | 53 | |
RA2159 | 3 | IL-9 | 74.5 | 66 | |||||||
N2586 | IGF-I | 100 | ug/mL | 3 | IL-9 | 81.5 | 68 | ||||
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | IL-9 | 73.0 | 61 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL-9 | 71.0 | 79 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL-9 | 87.0 | 70 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL-9 | 73.5 | 76 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | IL-9 | 70.0 | 87 | |
N2586 | 3 | IL-9 | 87.0 | 63 | |||||||
RA2159 | EGF | 100 | ng/mL | 3 | IL-9 | 64.0 | 60 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | IL-9 | 65.0 | 73 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL-9 | 68.0 | 72 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL-9 | 79.0 | 58 |